Michael J Fox Foundation for Parkinson’s Research-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Michael J Fox Foundation for Parkinson's Research - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014120
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Michael J Fox Foundation for Parkinson’s Research (Michael J. Fox) is a research foundation that conducts research on Parkinson’s disease. The foundation offers research and development of therapies. It provides drug development and other research activities in the area of Parkinson’s disease. Michael J. Fox offers treatments, which include deep brain stimulation, medication and therapy development. The foundation operates through drug development service companies, pharmaceuticals and healthcare centers. It collaborates with other companies to enhance its research programs through funding, in-kind contributions, strategic input, and others. Michael J. Fox is headquartered in New York, the US.

Michael J Fox Foundation for Parkinson’s Research – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Michael J Fox Foundation for Parkinson’s Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Michael J Fox Foundation for Parkinson’s Research, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Michael J Fox Foundation for Parkinson’s Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Michael J Fox Foundation for Parkinson’s Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Michael J Fox Foundation for Parkinson’s Research, Medical Devices Deals, 2011 to YTD 2017 9
Michael J Fox Foundation for Parkinson’s Research, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Michael J Fox Foundation for Parkinson’s Research, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
MJFF Acquires Research Tools from Imago Pharma 12
Partnerships 13
Michael J. Fox Foundation Plans to Enter into Co-Development Agreement with Van Andel Research Institute and Cure Parkinson’s Trust 13
Charles River Labs Expands its Agreement with Michael J. Fox Foundation for Parkinson’s Research 14
MJFF Enters into Agreement with Prothena 15
MJFF, Jefferson And Taconic Enter Into Co-Development Agreement 16
BioFocus Extends Agreement With Michael J. Fox Foundation For Parkinson’s Disease 17
BioFocus Enters Into Agreement With Michael J. Fox Foundation For Parkinson’s Disease 18
Merger 19
Michael J. Fox Foundation and Michael Stern Parkinson’s Research Foundation Merge 19
Michael J Fox Foundation for Parkinson’s Research – Key Competitors 20
Michael J Fox Foundation for Parkinson’s Research – Key Employees 21
Michael J Fox Foundation for Parkinson’s Research – Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Corporate Communications 24
Apr 19, 2017: The Michael J. Fox Foundation Promotes Sohini Chowdhury to Deputy Chief Executive Officer 24
Government and Public Interest 25
Oct 03, 2017: AC Immune Awarded Continuation of 2015 Grant from The Michael J. Fox Foundation for Parkinsons Research 25
May 20, 2017: Wim Versees receives Michael J. Fox Foundation grant for investigating Parkinson’s disease-associated protein 26
Sep 29, 2016: Cognition Therapeutics (CogRx) Receives Michael J. Fox Foundation Grant to Study Inhibitors of Alpha-synuclein Oligomers for the Treatment of Parkinson’s Disease 27
Jun 16, 2016: La Jolla Institute Receives Research Grant from The Michael J. Fox Foundation 28
May 25, 2016: National Stem Cell Foundation and Michael J. Fox Foundation Partner to Support Parkinson’s Cell Replacement Therapy 29
Feb 22, 2016: Saniona: Awarded grant by The Michael J. Fox Foundation for Parkinson’s Research 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare, Key Facts 2
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Michael J Fox Foundation for Parkinson's Research, Deals By Therapy Area, 2011 to YTD 2017 8
Michael J Fox Foundation for Parkinson's Research, Medical Devices Deals, 2011 to YTD 2017 9
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
MJFF Acquires Research Tools from Imago Pharma 12
Michael J. Fox Foundation Plans to Enter into Co-Development Agreement with Van Andel Research Institute and Cure Parkinson's Trust 13
Charles River Labs Expands its Agreement with Michael J. Fox Foundation for Parkinson’s Research 14
MJFF Enters into Agreement with Prothena 15
MJFF, Jefferson And Taconic Enter Into Co-Development Agreement 16
BioFocus Extends Agreement With Michael J. Fox Foundation For Parkinson's Disease 17
BioFocus Enters Into Agreement With Michael J. Fox Foundation For Parkinson's Disease 18
Michael J. Fox Foundation and Michael Stern Parkinson's Research Foundation Merge 19
Michael J Fox Foundation for Parkinson's Research, Key Competitors 20
Michael J Fox Foundation for Parkinson's Research, Key Employees 21

★海外企業調査レポート[Michael J Fox Foundation for Parkinson’s Research-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • St. George’s University of London-製薬・医療分野:企業M&A・提携分析
    Summary St. George's University of London (SGUL), a subsidiary of University of London is a medical and healthcare education provider that offers undergraduate and post graduate courses. The university’s undergraduate courses include biomedical science BSc, healthcare practice DipHE and BSc, healthc …
  • Nelnet, Inc.:企業の戦略・SWOT・財務情報
    Nelnet, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nelnet, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Intermountain Healthcare Inc:企業の戦略的SWOT分析
    Intermountain Healthcare Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • BDI – BioEnergy International AG:企業の戦略的SWOT分析
    BDI - BioEnergy International AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Micro Focus International Plc (MCRO):企業の財務・戦略的SWOT分析
    Micro Focus International Plc (MCRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • New England Biolabs Inc-製薬・医療分野:企業M&A・提携分析
    Summary New England Biolabs Inc (NEB) is a life science company that develops recombinant and native enzymes for genomic research. The company offers products such as competent cells, DNA plasmids, protein tools, buffers and strains, and others. It has applications in cloning and synthetic biology, …
  • Trinidad Drilling Ltd (TDG):企業の財務・戦略的SWOT分析
    Summary Trinidad Drilling Ltd (Trinidad Drilling) is an oil and gas company that offers drilling services. The company’s services include land and barge drilling, coring and presetting, well servicing, rig design and management, rig fleet management, and technical support services. Its in-house manu …
  • Dais Analytic Corps (DLYT):企業の財務・戦略的SWOT分析
    Summary Dais Analytic Corps (Dais) is an alternative energy company that provides industry changing and nano technology based applications. The company's products include ultra capacitors, clean water systems, heating and cooling equipment, among others. It also provides NanoAir, NanoCap, ConsERV an …
  • Boehringer Ingelheim GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Boehringer Ingelheim GmbH (Boehringer), a subsidiary of CH Boehringer Sohn AG & Co KG is a pharmaceutical company that conducts research, development, manufacture and sale of pharmaceuticals. It offers a wide range of products including human diseases, animal health care products and biophar …
  • NRG Energy Inc (NRG)-エネルギー分野:企業M&A・提携分析
    Summary NRG Energy, Inc. (NRG) is an integrated energy company that produces, sells and delivers energy, and energy products and services. The company generates power using diverse sources such as coal, natural gas, nuclear, oil, wind and solar. It trades wholesale energy, capacity, fuel and related …
  • Samsung Biologics Co Ltd (207940):製薬・医療:M&Aディール及び事業提携情報
    Summary Samsung Biologics Co Ltd (Samsung Biologics) is a biologics development and manufacturing company. The company’s business activities include process development, contract manufacturing, aseptic fill and finish and project management. Samsung Biologics cell culture development process include …
  • GRP Limited (GRPLTD):企業の財務・戦略的SWOT分析
    GRP Limited (GRPLTD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Acorda Therapeutics Inc (ACOR):企業の財務・戦略的SWOT分析
    Acorda Therapeutics Inc (ACOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Vericel Corp (VCEL)-医療機器分野:企業M&A・提携分析
    Summary Vericel Corp (Vericel) formerly Aastrom Biosciences, Inc. is a medical device company that develops patient-specific expanded cellular therapies to repair and regenerate damaged tissue for the treatment of severe, chronic ischemic cardiovascular diseases. It markets two autologous cell thera …
  • Chemed Corp (CHE):企業の財務・戦略的SWOT分析
    Summary Chemed Corp (Chemed) is a diversified company. The company operates through its segments including Vitas and Roto-Rooter. Its Vitas segment provides end-of-life hospice care for heart disease, stroke, multiple sclerosis, lung disease, liver disease, and kidney diseases, among others. Chemed …
  • NRW Holdings Ltd:企業の戦略・SWOT・財務情報
    NRW Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary NRW Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Edmond De Rothschild (Suisse) S.A.
    Edmond De Rothschild (Suisse) S.A. - Strategy, SWOT and Corporate Finance Report Summary Edmond De Rothschild (Suisse) S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • ABB Ltd (ABBN):企業の財務・戦略的SWOT分析
    ABB Ltd (ABBN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Tokyo Broadcasting System Holdings, Inc. (9401):企業の財務・戦略的SWOT分析
    Tokyo Broadcasting System Holdings, Inc. (9401) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Sasol Ltd (SOL)-エネルギー分野:企業M&A・提携分析
    Summary Sasol Ltd (Sasol) is an integrated energy and chemical company. It develops and commercializes technologies; and builds and operates facilities to produce a range of products, including liquid fuels, chemicals, and low-carbon electricity. The company’s product offerings include olefins and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆